Evidence map›Paper›PMID 27343545›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.

Andrea J Low, Gitau Mburu, Nicky J Welton, Margaret T May, Charlotte F Davies, Clare French, Katy M Turner, Katharine J Looker, Hannah Christensen, Susie McLean and 5 more

Registry-linked trialOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04601064 (Peer Supported Collaborative Care to Increase Engagement in Mental Health and Substance Use Disorder Care in HIV Care Settings), which is not on this map. Cited by 150 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 9 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04601064 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

Peer Supported Collaborative Care to Increase Engagement in Mental Health and Substance Use Disorder Care in HIV Care Settings

TypeinterventionalSponsorJohns Hopkins UniversityRan2022 to 2026Enrolled405ConditionsHIV Infections, Substance Use Disorders, Mental Health Disorder, AddictionArmsCollaborative Care Model
3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 9 syntheses or guidelines pooled it, 226 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Andrea J LowSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Gitau MburuInternational HIV/AIDS Alliance, Brighton.
Nicky J WeltonSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Margaret T MaySchool of Social and Community Medicine, University of Bristol, United Kingdom.
Charlotte F DaviesSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Clare FrenchSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Katy M TurnerSchool of Clinical Veterinary Sciences, University of Bristol.
Katharine J LookerSchool of Clinical Veterinary Sciences, University of Bristol.
Hannah ChristensenSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Susie McLeanInternational HIV/AIDS Alliance, Brighton.
Tim RhodesLondon School of Hygiene and Tropical Medicine, United Kingdom.
Lucy PlattLondon School of Hygiene and Tropical Medicine, United Kingdom.
Matthew HickmanSchool of Social and Community Medicine, University of Bristol, United Kingdom.
Andy GuiseUniversity of California, San Diego.
Peter VickermanSchool of Social and Community Medicine, University of Bristol, United Kingdom.
University of Bristol · GBInternational HIV/AIDS Alliance · GBLondon School of Hygiene & Tropical Medicine · GBUniversity of California, San Diego · US

Funding

Modeling Structural HIV Determinants in Substance Users and related populationsR01DA037773 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA, STRATHDEE, STEFFANIE A. · 2015 to 2017
$1.4M
Department of Health 12/3070/13Medical Research Council MR/J002380/1NIDA NIH HHS R01 DA037773
6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV)-infected people who inject drugs (PWID) frequently encounter barriers accessing and remaining on antiretroviral therapy (ART). Some studies have suggested that opioid substitution therapy (OST) could facilitate PWID's engagement with HIV services. We conducted a systematic review and meta-analysis to evaluate the impact of concurrent OST use on ART-related outcomes among HIV-infected PWID.

methodsWe searched Medline, PsycInfo, Embase, Global Health, Cochrane, Web of Science, and Social Policy and Practice databases for studies between 1996 to November 2014 documenting the impact of OST, compared to no OST, on ART outcomes. Outcomes considered were coverage and recruitment onto ART, adherence, viral suppression, attrition from ART, and mortality. Meta-analyses were conducted using random-effects modeling, and heterogeneity assessed using Cochran Q test and I(2) statistic.

resultsWe identified 4685 articles, and 32 studies conducted in North America, Europe, Indonesia, and China were included. OST was associated with a 69% increase in recruitment onto ART (hazard ratio [HR], 1.69; 95% confidence interval [CI], 1.32-2.15), a 54% increase in ART coverage (odds ratio [OR], 1.54; 95% CI, 1.17-2.03), a 2-fold increase in adherence (OR, 2.14; 95% CI, 1.41-3.26), and a 23% decrease in the odds of attrition (OR, 0.77; 95% CI, .63-.95). OST was associated with a 45% increase in odds of viral suppression (OR, 1.45; 95% CI, 1.21-1.73), but there was limited evidence from 6 studies for OST decreasing mortality for PWID on ART (HR, 0.91; 95% CI, .65-1.25).

conclusionsThese findings support the use of OST, and its integration with HIV services, to improve the HIV treatment and care continuum among HIV-infected PWID.

Indexed as

Opiate Substitution TreatmentAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBuprenorphineCD4 Lymphocyte CountHIV InfectionsHumansMedication AdherenceMethadoneOdds RatioPublication BiasSubstance-Related DisordersTreatment OutcomeViral LoadAnti-Retroviral AgentsBuprenorphineMethadoneantiretroviral treatment (ART)HIVmedication-assisted therapy for opioid dependence (MAT)people who inject drugs (PWID)systematic review

Identifiers

PMID27343545
PMCPMC5036913
OpenAlexW2470822429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.